
    
      It is a prospective, double-blind, randomized controlled trial. Patients with painful chronic
      pancreatitis and pancreatic stones (> 5 mm in diameter) who are treated with ESWL at Changhai
      Hospital will be randomly allocated to indomethacin or placebo therapy before the procedure.
    
  